Earlier this month The American Society of Clinical Oncology (ASCO) held their annual meeting in Chicago, IL. The opening session presentation was delivered by ASCO President Eric P. Winer, MD, FASCO, a dedicated clinical oncologist for more than 30…
NBDF History In 1948, the foundation got its start as simply “The Hemophilia Foundation” – then in 1956, the foundation formally incorporated into what is known today as – the National Hemophilia Foundation. Even then, it was…
#block-recentonlineeducation {
display:none;
}
Clotting Cascade 3D VideoCome along on a 3D adventure in this video about how blood clots when there is a bleed or injury. The 3D animation in this video shows each of the proteins (called clotting…
The U.S. Food and Drug Administration (FDA) has approved BioMarin’s ROCTAVIAN™ (valoctocogene roxaparvovec-rvox) gene therapy product for the treatment of adults with severe hemophilia A without antibodies to adeno-associated virus serotype 5 (AAV5…
Sanofi recently shared positive data from the Phase 3 XTEND-Kids study, which is currently evaluating once weekly prophylaxis with ALTUVIIIO™ in previously treated patients younger than 12 years of age with severe hemophilia A.ALTUVIIIO is Sanofi’s…
Federal Updates:HELP Copays Act: S. 1375, the Senate version of the HELP Copays Act currently has twelve cosponsors, and HR 830, the House version of the bill, has 56 cosponsors. The All…
Peggy, a longtime community member shares her family's history of involvement and advocacy. To learn more about Peggy's involvement in the bleeding disorders community watch the full interview or read the transcript below.
Can…
The U.S. Food and Drug Administration (FDA) has approved Opill (norgestrel), the first daily oral contraceptive approved for use in the U.S. without a prescription.
According to a new FDA news release, this approval will allow consumers to…